Person profile
Public information reviewedRob Readnour, Ph.D.
Board role
Class I Director · AN2 Therapeutics, Inc. (NASDAQ: ANTX)
AN2 Therapeutics, Inc. (NASDAQ: ANTX)
Class I Director · Current mandate
Board Director · Us Listed
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 5, 2026
Alpha Registry